Interpace Diagnostics to Present at NobleCon14 on January 29
25 janv. 2018 08h00 HE
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J. , Jan. 25, 2018 (GLOBE NEWSWIRE) -- INTERPACE DIAGNOSTICS GROUP, INC.(NASDAQ:IDXG), a fully integrated commercial and bioinformatics company that provides clinically useful...
Interpace Diagnostics Recognized as One of the Top 20 Bioinformatics Solutions Providers
08 janv. 2018 08h00 HE
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or the “Company”), a fully integrated commercial and bioinformatics company that...
Interpace Diagnostics Announces Agreement with ARUP Laboratories
18 déc. 2017 08h00 HE
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J., Dec. 18, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial company that provides clinically...
Interpace Diagnostics Announces New York State Approval of New Product
16 nov. 2017 08h00 HE
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Corp. (NASDAQ:IDXG), a fully integrated commercial company that provides clinically useful molecular diagnostic tests and...
Interpace Diagnostics Group Reports Third Quarter 2017 Financial Results, Business Progress and Recent Accomplishments
13 nov. 2017 08h00 HE
|
Interpace Diagnostics Group, Inc.
Q3-2017 Net Revenues of Over $4 Million Growing 27% Over Prior Year Quarter Represents Fourth Straight Quarter of Sequential Revenue GrowthNet Loss for the Quarter & Year to Date a 56% and 51%...
Interpace Diagnostics to Host Conference Call and Webcast to Discuss Third Quarter 2017 Financial Results and Business Progress on Monday November 13, 2017
09 nov. 2017 07h30 HE
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial company that provides clinically...
Interpace Diagnostics Designated as “Company of the Month” by G2 Intelligence
25 oct. 2017 09h00 HE
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J., Oct. 25, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial company that provides clinically...
Interpace Diagnostics Presents Important Data at the World Congress of Gastroenterology at American College of Gastroenterology (ACG) 2017
23 oct. 2017 08h45 HE
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J., Oct. 23, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group (NASDAQ:IDXG), a fully integrated commercial company that provides clinically useful molecular diagnostic tests and...
Interpace Diagnostics Presents New Data from Over 3,400 Patients Tested with ThyGenX®/ThyraMIR®
18 oct. 2017 08h45 HE
|
Interpace Diagnostics Group, Inc.
VICTORIA, British Columbia, Oct. 18, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial company that provides...
Interpace Diagnostics to Present at the Dawson James Securities 3rd Annual Small Cap Growth Stock Conference
17 oct. 2017 08h30 HE
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J., Oct. 17, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) today announced that Jack Stover, the Company’s President and CEO is scheduled to present on...